Risk stratification for prevention of sudden cardiac death

Current Treatment Options in Cardiovascular Medicine

Volumn 14, Issue 1, 2012, Pages 81-90

  Saha, Paban ^a   Goldberger, Jeffrey J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

ICD; Prevention; Risk stratification; Sudden cardiac death; VF; VT

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FISH OIL; PLACEBO;

ARTICLE; BRADYCARDIA; BRUGADA SYNDROME; CARDIOVASCULAR MAGNETIC RESONANCE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; DIET THERAPY; DRUG MEGADOSE; ELECTROCARDIOGRAM; EXERCISE; GENETIC SCREENING; HEART ARRHYTHMIA; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK POPULATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC CARDIOMYOPATHY; LIFESTYLE; LONG QT SYNDROME; MORTALITY; NONISCHEMIC CARDIOMYOPATHY; PRIMARY PREVENTION; QT PROLONGATION; RESUSCITATION; RISK ASSESSMENT; SCREENING TEST; SECONDARY PREVENTION; SUDDEN DEATH; SURVIVAL; SYNCOPE; TACHYCARDIA; TREATMENT INDICATION;

EID: 84857629510     PISSN: 10928464     EISSN: 15343189     Source Type: Journal    
DOI: 10.1007/s11936-011-0160-7     Document Type: Article

References (55)

1. JJ Goldberger ME Cain SH Hohnloser AH Kadish BP Knight MS Lauer, et al. 2008 American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention Circulation 118 14 1497 1518 10.1161/circulationaha. 107.189375 18833586 10.1161/CIRCULATIONAHA.107.189375
2. SS Chugh 2010 Early identification of risk factors for sudden cardiac death Nat Rev Cardiol 7 6 318 326 10.1038/nrcardio.2010.52 20421887 10.1038/nrcardio.2010.52
3. AC Pouleur E Barkoudah H Uno H Skali PV Finn SL Zelenkofske, et al. 2010 Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both Circulation 122 6 597 602 10.1161/circulationaha.110.940619 20660803 10.1161/CIRCULATIONAHA.110.940619
4. CM Pratt PS Greenway MH Schoenfeld ML Hibben JA Reiffel 1996 Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials Circulation 93 3 519 524 8565170 1:STN:280:DyaK287ls1SisA%3D%3D (Pubitemid 26043611)
5. UJ Gang C Jons RM Jorgensen SZ Abildstrom J Haarbo MD Messier, et al. 2010 Heart rhythm at the time of death documented by an implantable loop recorder Europace 12 2 254 260 10.1093/europace/eup383 20019013 10.1093/europace/eup383
6. G Nichol E Thomas CW Callaway J Hedges JL Powell TP Aufderheide, et al. 2008 Regional variation in out-of-hospital cardiac arrest incidence and outcome JAMA 300 12 1423 1431 10.1001/jama.300.12.1423 18812533 10.1001/jama.300.12.1423 1:CAS:528:DC%2BD1cXhtFKhsr3F
7. B McNally R Robb M Mehta K Vellano AL Valderrama PW Yoon, et al. 2011 Out-of-Hospital Cardiac Arrest Surveillance - Cardiac Arrest Registry to Enhance Survival (CARES), United States, October 1, 2005-December 31, 2010 MMWR Surveill Summ. 60 8 1 19 21796098
8. PC Ko WJ Chen CH Lin MH Ma FY Lin 2005 Evaluating the quality of prehospital cardiopulmonary resuscitation by reviewing automated external defibrillator records and survival for out-of-hospital witnessed arrests Resuscitation 64 2 163 169 10.1016/j.resuscitation.2004.08.013 15680524 10.1016/j.resuscitation.2004.08.013 (Pubitemid 40175084)
9. JJ Goldberger AE Buxton M Cain O Costantini DV Exner BP Knight, et al. 2011 Risk stratification for arrhythmic sudden cardiac death: identifying the roadblocks Circulation 123 21 2423 2430 10.1161/circulationaha.110.959734 21632516 10.1161/CIRCULATIONAHA.110.959734
10. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. New Engl J Med. 1997;337 (22):1576-84. doi:10. 1056/NEJM199711273372202. (Pubitemid 27509760)
11. SJ Connolly M Gent RS Roberts P Dorian D Roy RS Sheldon, et al. 2000 Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone Circulation 101 11 1297 1302 10725290 1:CAS:528:DC%2BD3cXisVSqs7o%3D (Pubitemid 30158618)
12. KH Kuck R Cappato J Siebels R Ruppel 2000 Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH) Circulation 102 7 748 754 10942742 1:CAS:528:DC%2BD3cXmtlSmurk%3D (Pubitemid 30648765)
13. SJ Connolly AP Hallstrom R Cappato EB Schron KH Kuck DP Zipes, et al. 2000 Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study Eur Heart J 21 24 2071 2078 10.1053/euhj.2000.2476 11102258 10.1053/euhj.2000.2476 1:STN:280:DC%2BD3M7gvVCqtA%3D%3D (Pubitemid 32006221)
14. AE Buxton KL Lee GE Hafley DG Wyse JD Fisher MH Lehmann, et al. 2002 Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial Circulation 106 19 2466 2472 12417544 10.1161/01.CIR.0000037224.15873.83 1:CAS:528:DC%2BD38XotFKrtbs%3D (Pubitemid 35278803)
15. AJ Moss WJ Hall DS Cannom JP Daubert SL Higgins H Klein, et al. 1996 Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators N Engl J Med. 335 26 1933 1940 10.1056/nejm199612263352601 8960472 10.1056/NEJM199612263352601 1:STN:280:DyaK2s7hsF2isw%3D%3D (Pubitemid 26428217)
16. AJ Moss W Zareba WJ Hall H Klein DJ Wilber DS Cannom, et al. 2002 Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 12 877 883 10.1056/NEJMoa013474 11907286 10.1056/NEJMoa013474 (Pubitemid 34984635)
17. G Steinbeck D Andresen K Seidl J Brachmann E Hoffmann D Wojciechowski, et al. 2009 Defibrillator implantation early after myocardial infarction N Engl J Med 361 15 1427 1436 10.1056/NEJMoa0901889 19812399 10.1056/NEJMoa0901889 1:CAS:528:DC%2BD1MXht1GiurnL
18. SH Hohnloser KH Kuck P Dorian RS Roberts JR Hampton R Hatala, et al. 2004 Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction N Engl J Med 351 24 2481 2488 10.1056/NEJMoa041489 15590950 10.1056/NEJMoa041489 1:CAS:528:DC%2BD2cXhtVGksbnN (Pubitemid 39603155)
19. JJ Goldberger R Passman 2009 Implantable cardioverter-defibrillator therapy after acute myocardial infarction J Am Coll Cardiol 54 22 2001 2005 10.1016/j.jacc.2009.08.018 19926004 10.1016/j.jacc.2009.08.018
20. GH Bardy KL Lee DB Mark JE Poole DL Packer R Boineau, et al. 2005 Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 3 225 237 10.1056/NEJMoa043399 15659722 10.1056/NEJMoa043399 1:CAS:528:DC%2BD2MXmslShtw%3D%3D (Pubitemid 40110811)
21. A Kadish A Dyer JP Daubert R Quigg NA Estes KP Anderson, et al. 2004 Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 21 2151 2158 10.1056/NEJMoa033088 15152060 10.1056/NEJMoa033088 1:CAS:528:DC%2BD2cXktF2is7Y%3D (Pubitemid 38637995)
22. AS Desai JC Fang WH Maisel KL Baughman 2004 Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials JAMA. 292 23 2874 2879 10.1001/jama.292.23.2874 15598919 10.1001/jama.292.23.2874 1:CAS:528: DC%2BD2cXhtFWru7bN (Pubitemid 39628235)
23. WJ McKenna ER Behr 2002 Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death Heart 87 2 169 176 11796562 10.1136/heart.87.2.169 (Pubitemid 34098386)
24. AE Epstein JP DiMarco KA Ellenbogen NAM Estes RA Freedman LS Gettes, et al. 2008 ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities J Am Coll Cardiol 51 21 e1 e62 10.1016/j.jacc.2008.02.032 18498951 10.1016/j.jacc.2008.02.032 (Pubitemid 351689050)
25. P Delise G Allocca E Marras C Giustetto F Gaita L Sciarra, et al. 2010 Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach Eur Hear J 32 2 169 176 10.1093/eurheartj/ehq381 10.1093/eurheartj/ehq381
26. P Muthappan H Calkins 2008 Arrhythmogenic right ventricular dysplasia Prog Cardiovasc Dis 51 1 31 43 10.1016/j.pcad.2008.01.002 18634916 10.1016/j.pcad.2008.01.002 (Pubitemid 351957825)
27. FI Marcus WJ McKenna D Sherrill C Basso B Bauce DA Bluemke, et al. 2010 Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria Circulation 121 13 1533 1541 10.1161/circulationaha.108.840827 20172911 10.1161/CIRCULATIONAHA.108.840827
28. HC Patel H Calkins 2010 Arrhythmogenic right ventricular dysplasia Curr Treat Options Cardiovasc Med 12 6 598 613 10.1007/s11936-010-0097-2 21063936 10.1007/s11936-010-0097-2
29. ES Kaufman 2009 Mechanisms and clinical management of inherited channelopathies: Long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome Hear Rhythm 6 8 S51 S55 10.1016/j.hrthm.2009.02.009 10.1016/j.hrthm.2009.02.009
30. IA Brouwer PL Zock AJ Camm D Bocker RN Hauer EF Wever, et al. 2006 Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial JAMA. 295 22 2613 2619 10.1001/jama.295.22.2613 16772624 10.1001/jama.295.22.2613 1:CAS:528: DC%2BD28XlvFWmtb8%3D (Pubitemid 43882336)
31. MH Raitt WE Connor C Morris J Kron B Halperin SS Chugh, et al. 2005 Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators JAMA: J Am Med Assoc 293 23 2884 2891 10.1001/jama.293.23.2884 10.1001/jama.293.23.2884 1:CAS:528:DC%2BD2MXltlaqs7s%3D (Pubitemid 41029142)
32. M Mittleman D Siscovick 1996 Physical exertion as a trigger of myocardial infarction and sudden cardiac death Cardiol Clin 14 2 263 8724558 1:STN:280:DyaK28zitFWltA%3D%3D
33. JA Jolliffe K Rees RS Taylor D Thompson N Oldridge S Ebrahim 2001 Exercise-based rehabilitation for coronary heart disease Cochrane Database Syst Rev. 1 CD001800 10.1002/14651858.cd001800 11279730
34. R Lampert T Joska MM Burg WP Batsford CA McPherson D Jain 2002 Emotional and physical precipitants of ventricular arrhythmia Circulation 106 14 1800 1805 12356633 10.1161/01.CIR.0000031733.51374.C1
35. SJ Connolly P Dorian RS Roberts M Gent S Bailin ES Fain, et al. 2006 Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial JAMA. 295 2 165 171 10.1001/jama.295.2.165 16403928 10.1001/jama.295.2.165 1:CAS:528:DC%2BD28XislSlsw%3D%3D (Pubitemid 43076435)
36. I Sim KM McDonald PW Lavori CM Norbutas MA Hlatky 1997 Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death Circulation 96 9 2823 2829 9386144 1:CAS:528:DyaK2sXnvFajsLg%3D (Pubitemid 27500077)
37. JP Piccini JS Berger CM O'Connor 2009 Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials Eur Heart J. 30 10 1245 1253 10.1093/eurheartj/ehp100 19336434 10.1093/eurheartj/ehp100 1:CAS:528:DC%2BD1MXmtFCisro%3D
38. DB Mark 2006 Cost-Effectiveness of Defibrillator Therapy or Amiodarone in Chronic Stable Heart Failure: Results From the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Circulation 114 2 135 142 10.1161/circulationaha.105. 581884 16818817 10.1161/CIRCULATIONAHA.105.581884 1:CAS:528:DC%2BD28XmsVGjsLs%3D (Pubitemid 44420745)
39. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353(9146):9-13.
40. WS Colucci M Packer MR Bristow EM Gilbert JN Cohn MB Fowler, et al. 1996 Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group Circulation. 94 11 2800 2806 8941105 1:CAS:528:DyaK2sXlsVShtQ%3D%3D (Pubitemid 26411744)
41. A Hjalmarson S Goldstein B Fagerberg H Wedel F Waagstein J Kjekshus, et al. 2000 Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group JAMA. 283 10 1295 1302 10714728 10.1001/jama.283.10.1295 1:CAS:528:DC%2BD3cXitVCktbk%3D (Pubitemid 30129796)
42. TNMS Group 1981 Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction N Engl J Med 304 801 807 10.1056/NEJM198104023041401
43. A Hjalmarson 1997 Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period Am J Cardiol. 80 9B 35J 39J 9375948 10.1016/S0002-9149(97)00837-0 1:CAS:528:DyaK2sXnslyls7g%3D (Pubitemid 27518556)
44. G Olsson J Wikstrand I Warnold V Manger Cats D McBoyle J Herlitz, et al. 1992 Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials Eur Heart J. 13 1 28 32 1533587 1:STN:280:DyaK383kvFemug%3D%3D
45. AP Hallstrom LA Cobb BH Yu WD Weaver CE Fahrenbruch 1991 An antiarrhythmic drug experience in 941 patients resuscitated from an initial cardiac arrest between 1970 and 1985 Am J Cardiol 68 10 1025 1031 1927915 10.1016/0002-9149(91)90490-C 1:STN:280:DyaK38%2FisFyrtA%3D%3D
46. V Rankovic J Karha R Passman AH Kadish JJ Goldberger 2002 Predictors of appropriate implantable cardioverter-defibrillator therapy in patients with idiopathic dilated cardiomyopathy Am J Cardiol 89 9 1072 1076 11988198 10.1016/S0002-9149(02)02278-6 (Pubitemid 34462853)
47. GD Sanders MA Hlatky DK Owens 2005 Cost-effectiveness of implantable cardioverter-defibrillators N Engl J Med 353 14 1471 1480 10.1056/NEJMsa051989 16207849 10.1056/NEJMsa051989 1:CAS:528:DC%2BD2MXhtVOisL%2FN (Pubitemid 41400921)
48. F Jacq G Foulldrin A Savoure F Anselme A Baguelin-Pinaud A Cribier, et al. 2009 A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients Gen Hosp Psychiatry. 31 3 266 273 10.1016/j.genhosppsych.2009.01.003 19410106 10.1016/j.genhosppsych.2009.01.003
49. LA Prudente J Reigle C Bourguignon DE Haines JP DiMarco 2006 Psychological indices and phantom shocks in patients with ICD J Interv Card Electrophysiol 15 3 185 190 10.1007/s10840-006-9010-z 17019638 10.1007/s10840-006-9010-z (Pubitemid 44510961)
50. Larsen GK, Evans J, Lambert WE, Chen Y, Raitt M. Shocks burden and increased mortality in implantable cardioverter defibrillator patients. Heart Rhythm. 2011;8(12):1881-6.
51. JE Poole GW Johnson AS Hellkamp J Anderson DJ Callans MH Raitt, et al. 2008 Prognostic importance of defibrillator shocks in patients with heart failure N Engl J Med 359 10 1009 1017 10.1056/NEJMoa071098 18768944 10.1056/NEJMoa071098 1:CAS:528:DC%2BD1cXhtVymurbN
52. A Lubinski A Bissinger L Boersma A Leenhardt B Merkely A Oto, et al. 2011 Determinants of geographic variations in implantation of cardiac defibrillators in the European Society of Cardiology member countries-data from the European Heart Rhythm Association White Book Europace 13 5 654 662 10.1093/europace/ eur066 21454333 10.1093/europace/eur066
53. RG Assomull SK Prasad J Lyne G Smith ED Burman M Khan, et al. 2006 Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy J Am Coll Cardiol 48 10 1977 1985 10.1016/j.jacc.2006.07.049 17112987 10.1016/j.jacc.2006.07.049 (Pubitemid 44738448)
54. D Bello DS Fieno RJ Kim FS Pereles R Passman G Song, et al. 2005 Infarct morphology identifies patients with substrate for sustained ventricular tachycardia J Am Coll Cardiol 45 7 1104 1108 10.1016/j.jacc.2004.12.057 15808771 10.1016/j.jacc.2004.12.057 (Pubitemid 40432446)
55. S Fluechter J Kuschyk C Wolpert C Doesch C Veltmann D Haghi, et al. 2010 Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy J Cardiovasc Magn Reson 12 30 10.1186/1532-429x-12- 30 20492668 10.1186/1532-429X-12-30